Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia

Leukemia Research

Volumn 70, Issue , 2018, Pages 25-33

  Maďarová, Martina ^a   Mucha, Rastislav ^a   Hresko, Stanislav ^a   Makarová, Zuzana ^a   Gdovinová, Zuzana ^b   Szilasiová, Jarmila ^b   Vitková, Marianna ^b   Guman, Tomáš ^b   Štecová, Natalia ^b   Dobransky, Tomas ^a  

^a DB Biotech   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

B cells; CD23; Chronic lymphocytic leukemia; Flow cytometry; Protein phosphorylation

Indexed keywords

CD23 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOTRANSFERASE; SERINE; THREONINE; IMMUNOGLOBULIN E RECEPTOR; PROTEIN KINASE C; TUMOR MARKER;

AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; BONE MARROW; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

B-LYMPHOCYTES; BIOMARKERS, TUMOR; BONE MARROW; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, IGE;

EID: 85047081238     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2018.05.002     Document Type: Article

References (36)

1. Hallek, M., Pflug, N., Chronic lymphocytic leukemia. Ann. Oncol., 21(Suppl. 7), 2010 vii154–164.
2. Eichhorst, B., Dreyling, M., Robak, T., Montserrat, E., Hallek, M., Chronic lymphocytic leukemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 22(Suppl. 6), 2011 vi50–54.
3. Gaidano, G., Foa, R., Dalla-Favera, R., Molecular pathogenesis of chronic lymphocytic leukemia. J. Clin. Invest. 122:10 (2012), 3432–3438.
4. Oppezzo, P., Dighiero, G., Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia. Blood Cancer J., 3, 2013, e149.
5. Fournier, S., Rubio, M., Delespesse, G., Sarfati, M., Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 84:6 (1994), 1881–1886.
6. Bonnefoy, J.Y., Lecoanet-Henchoz, S., Gauchat, J.F., Graber, P., Aubry, J.P., Jeannin, P., Plater-Zyberk, C., Structure and functions of CD23. Int. Rev. Immunol. 16:1–2 (1997), 113–128.
7. Sarfati, M., Fournier, S., Wu, C.Y., Delespesse, G., Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol. Res. 11:3–4 (1992), 260–272.
8. Acharya, M., Borland, G., Edkins, A.L., Maclellan, L.M., Matheson, J., Ozanne, B.W., Cushley, W., CD23/FcepsilonRII: molecular multi-tasking. Clin. Exp. Immunol. 162:1 (2010), 12–23.
9. Kolb, J.P., Renard, D., Dugas, B., Genot, E., Petit-Koskas, E., Sarfati, M., Delespesse, G., Poggioli, J., Monoclonal anti-CD23 antibodies induce a rise in [Ca2+]i and polyphosphoinositide hydrolysis in human activated B cells. Involvement of a Gp protein. J. Immunol. 145:2 (1990), 429–437.
10. Kolb, J.P., Abadie, A., Proschnicka-Chalufour, A., de Gramont, A., Poggioli, J., CD23-mediated cell signalling. J. Lipid Med. Cell Signal. 9:1 (1994), 27–35.
11. Yokota, A., Kikutani, H., Tanaka, T., Sato, R., Barsumian, E.L., Suemura, M., Kishimoto, T., Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 55:4 (1988), 611–618.
12. Delespesse, G., Sarfati, M., Hofstetter, H., Human IgE-binding factors. Immunol. Today 10:5 (1989), 159–164.
13. Fournier, S., Yang, L.P., Delespesse, G., Rubio, M., Biron, G., Sarfati, M., The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br. J. Haematol. 89:2 (1995), 373–379.
14. Yokota, A., Yukawa, K., Yamamoto, A., Sugiyama, K., Suemura, M., Tashiro, Y., Kishimoto, T., Kikutani, H., Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. Proc. Natl. Acad. Sci. U. S. A. 89:11 (1992), 5030–5034.
15. Schmid, C., Isaacson, P.G., Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study. Histopathology 24:5 (1994), 445–451.
16. Soma, L.A., Craig, F.E., Swerdlow, S.H., The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum. Pathol. 37:2 (2006), 152–159.
17. Caligaris-Cappio, F., Hamblin, T.J., B-cell chronic lymphocytic leukemia: a bird of a different feather. J. Clin. Oncol. 17:1 (1999), 399–408.
18. Andreeff, M., Darzynkiewicz, Z., Sharpless, T.K., Clarkson, B.D., Melamed, M.R., Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55:2 (1980), 282–293.
19. Fournier, S., Delespesse, G., Rubio, M., Biron, G., Sarfati, M., CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J. Clin. Invest. 89:4 (1992), 1312–1321.
20. Goller, M.E., Kneitz, C., Mehringer, C., Muller, K., Jelley-Gibbs, D.M., Gosselin, E.J., Wilhelm, M., Tony, H.P., Regulation of CD23 isoforms on B-chronic lymphocytic leukemia. Leuk. Res. 26:9 (2002), 795–802.
21. Sarfati, M., Fournier, S., Christoffersen, M., Biron, G., Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk. Res. 14:1 (1990), 47–55.
22. DiRaimondo, F., Albitar, M., Huh, Y., O'Brien, S., Montillo, M., Tedeschi, A., Kantarjian, H., Lerner, S., Giustolisi, R., Keating, M., The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease. Cancer 94:6 (2002), 1721–1730.
23. Jurisic, V., Colovic, N., Kraguljac, N., Atkinson, H.D., Colovic, M., Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters. Med. Oncol. 25:3 (2008), 315–322.
24. Krutzik, P.O., Nolan, G.P., Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 55:2 (2003), 61–70.
25. Damle, C., Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells, best practice & research. Clin. Haematol. 23:1 (2010), 33–45.
26. Ringshausen, I., Schneller, F., Bogner, C., Hipp, S., Duyster, J., Peschel, C., Decker, T., Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood 100:10 (2002), 3741–3748.
27. Frank, D.A., Mahajan, S., Ritz, J., B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest. 100:12 (1997), 3140–3148.
28. Rust, H.L., Thompson, P.R., Kinase consensus sequences: a breeding ground for crosstalk. ACS Chem. Biol. 6:9 (2011), 881–892.
29. Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Dohner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R., Kipps, T.J., Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:12 (2008), 5446–5456.
30. Kalpadakis, C., Pangalis, G.A., Sachanas, S., Vassilakopoulos, T.P., Kyriakaki, S., Korkolopoulou, P., Koulieris, E., Moschogiannis, M., Yiakoumis, X., Tsirkinidis, P., Kyrtsonis, M.C., Levidou, G., Papadaki, H.A., Panayiotidis, P., Angelopoulou, M.K., New insights into monoclonal B-cell lymphocytosis. BioMed Res. Int., 2014, 2014, 258917.
31. Yamasaki, T., Takahashi, A., Pan, J., Yamaguchi, N., Yokoyama, K.K., Phosphorylation of activation transcription factor-2 at serine 121 by protein kinase C controls c-Jun-mediated activation of transcription. J. Biol. Chem. 284:13 (2009), 8567–8581.
32. Alkan, S., Huang, Q., Ergin, M., Denning, M.F., Nand, S., Maududi, T., Paner, G.P., Ozpuyan, F., Izban, K.F., Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Am. J. Hematol. 79:2 (2005), 97–106.
33. D. El-Gamal, K., Williams, T.D., LaFollette, M., Cannon, J.S., Blachly, Y., Zhong, J.A., Woyach, E., Williams, F.T., Awan, J., Jones, L., Andritsos, K., Maddocks, C.H., Wu, C.S., Chen, A., Lehman, X., Zhang, R., Lapalombella, J.C. Byrd, PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL. Blood 124:9 (2014), 1481–1491.
34. Lee, C.E., Yoon, S.R., Pyun, K.H., Interleukin-4 signals regulating CD23 gene expression in human B cells: protein kinase C-independent signaling pathways. Cell. Immunol. 146:1 (1993), 171–185.
35. Burlinson, E.L., Graber, P., Bonnefoy, J.Y., Ozanne, B.W., Cushley, W., Soluble CD40 ligand induces expression of CD25 and CD23 in resting human tonsillar B lymphocytes. Eur. J. Immunol. 26:5 (1996), 1069–1073.
36. Chan, M.A., Gigliotti, N.M., Matangkasombut, P., Gauld, S.B., Cambier, J.C., Rosenwasser, L.J., CD23-mediated cell signaling in human B cells differs from signaling in cells of the monocytic lineage. Clin. Immunol. 137:3 (2010), 330–336.